Aurobindo Pharma

The market may attempt a bounce back after a four-day losing streak, but sustainability will be key to watch. Below are some short-term trading ideas to consider.

Stocks to Watch Today: Wakefit, Corona Remedies, Dr Reddys Labs, Wipro, Aurobindo Pharma, NLC India, Ashoka Buildcon, KEC in focus on 15 December

Stocks to Watch, 15 December: Stocks like Wipro, Dr Reddy's Laboratories, SMS Pharmaceuticals, Aurobindo Pharma, ESAF Small Finance Bank, NLC India, Ashoka Buildcon, KEC International, Bharat Electronics, Astra Microwave Products, One 97 Communications Paytm, Refex Industries, and Brigade Enterprises will be in focus on December 15.

Buy Aurobindo Pharma; target of Rs 1430: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1430 in its research report dated December 03, 2025.

Aurobindo Pharma incurring loss at China Plant; hopes to achieve break-even by Q4

The Hyderabad-based drug major remains confident about sustaining its growth momentum and driving value creation across all businesses, CFO S Subramanian said

Trade Spotlight: How should you trade Tata Communications, SAIL, Aurobindo Pharma, Samvardhana Motherson, Five-Star, and others on November 14?

The market is expected to remain rangebound until it decisively surpasses the previous day’s high. Below are some short-term trading ideas to consider.

Buy Aurobindo Pharma; target of Rs 1350: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 06, 2025.

Trade Spotlight: How should you trade Tech Mahindra, Aurobindo Pharma, Garden Reach, Bharat Forge, M&M, and others on November 12?

The market is likely to stay in positive terrain with improving sentiment. Below are some short-term trading ideas to consider.

Buy Aurobindo Pharma; target of Rs 1350: ICICI Securities

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 07, 2025.

Trade Spotlight: How should you trade Aurobindo Pharma, LIC, Godrej Properties, Punjab National Bank, Bharat Airtel, Cummins, and others on November 4?

The consolidation amid range-bound trading may continue in the upcoming sessions due to a lack of triggers. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade Federal Bank, NALCO, Eternal, KEI Industries, Karur Vysya Bank, and others on October 09?

The market is expected to consolidate further until a decisive breakout above the previous day's high occurs. Below are some short-term trading ideas to consider.

Aurobindo Pharma shares rise 4.5% as report says GTCR strikes $4.8-bn deal to buy Zentiva

A report said last month that Aurobindo Pharma was leading the race to buy Zentiva for up to $5.5 billion

Aurobindo Pharma shares fall on eight observations from USFDA

Aurobindo Pharma Share Price |

Stocks to Watch Today: Adani Power, SpiceJet, JP Associates, Zydus Life, Aurobindo Pharma, BHEL, HFCL, Ceigall, ACME, Prime Focus in focus on 08 September

Stocks to Watch, 08 Sept: Stocks like Adani Power, SpiceJet, Jaiprakash Associates, Zydus Lifesciences, Aurobindo Pharma, BHEL, HFCL, Ceigall India, ACME Solar Holdings, Prime Focus, Time Technoplast, Exxaro Tiles, and NTPC Green Energy will be in focus on September 08.

Stocks to Watch Today: Torrent Power, NCC, PG Electroplast, BHEL, Popular Vehicles, EPACK, Dharan Infra, Adani Power, Aurobindo Pharma in focus on 01 September

Stocks to Watch, 01 September: Stocks like Torrent Power, NCC, PG Electroplast, BHEL, Popular Vehicles, EPACK Durable, Dharan Infra, Adani Power, Aurobindo Pharma, Classic Electrodes (India), Anondita Medicare, and Shivashrit Foods will be in focus on 01 September.

Aurobindo Pharma clarifies, reports of Zentiva buyout 'premature', no binding agreement yet

Aurobindo Pharma said it 'regularly explores' various strategic opportunities, including potential acquisitions and partnerships, which can enhance shareholder value.

Aurobindo Pharma shares slide 4% on reports of Zentiva buyout talks

Aurobindo Pharma share price: Reports suggested it has emerged as the frontrunner to acquire Prague-based Zentiva for $5 to $5.5 billion. If completed, this would be the largest-ever acquisition by an Indian pharma company.

Buy Aurobindo Pharma; target of Rs 1300: ICICI Securities

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 06, 2025.

Buy Aurobindo Pharma; target of Rs 1300: Motilal Oswal

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 05, 2025.

Buy Aurobindo Pharma; target of Rs 1300: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 06, 2025.

Stocks to Watch Today: Paytm, Aurobindo Pharma, Aditya Infotech, DLF, Siemens Energy, Inox India, Godfrey Phillips, Azad Engineering in focus on 5 August

Stocks to Watch, 5 August: Stocks like One 97 Communications Paytm, Aurobindo Pharma, Aditya Infotech, Laxmi India Finance, DLF, Siemens Energy, Inox India, Godfrey Phillips, and Azad Engineering will be in focus on August 5.

Chartist Talk: Sudeep Shah shares 2 buy and 2 sell picks amid market caution; Nifty at risk below 24,400

The 24,400–24,350 zone is expected to act as an immediate support for Nifty. A sustained break below this could further accelerate the downside. On the flip side, the 50-day EMA zone of 24,900–24,950 now stands as a crucial hurdle, and any meaningful recovery would need to clear this zone with conviction, said Sudeep Shah of SBI Securities.